, Maryam Mohammadi
, Razie Alipour
, Mahtab Aligholipour
, Zahra Khezerlou *
, Darya Esmaeilbeigi
, Kazem Hajimohammadi
, Nima Sohrabi
| Study (Country, Design) | Population | Age, M (SD), years | Sample size, *n* | Follow-up | Tele-nursing intervention |
| Martorella et al., 2012 [26] (Canada, Pilot RCT) | Adults ≥18 years undergoing CABG and/or valve replacement | Int: 64.6 (8.2); Ctrl: 63.2 (9.9) | Int: 30; Ctrl: 30 | Days 1, 2, 3, and 7 post-surgeries | SOULAGE-TAVIE web-based; tailored 30-min session |
| Ding et al., 2024 [28] (China, RCT) | Adults aged 18–65 years after first MHVR for VHD | Int: 51.32 (0.77); Ctrl: 52.00 (1.08) | Int: 45; Ctrl: 45 | Day before; 1, 3, 6m | 6-month Banhu app |
| Jin et al., 2020 [22] (China, RCT) | CHD patients undergoing CABG, NYHA II–III | Int: 43.76 (6.57); Ctrl: 45.30 (7.31) | Int: 56; Ctrl: 56 | 10 days and 3 months | Family Network-Assisted Nursing (FNAN) |
| Yu et al., 2025 [31] (China, RCT) | Adults 18–79 with CHD after PCI | Int: 62.24 (11.09); Ctrl: 62.00 (10.99) | Int: 1,046; Ctrl: 1,021 | 12 months | WeChat-based platform |
| Mala et al., 2026 [24] (Thailand, RCT) | Adults ≥60 undergoing CABG, NYHA I–III | Int: 67.07 (6.56); Ctrl: 68.86 (6.83) | Int: 42; Ctrl: 42 | Baseline, 30, 90d | Telehealth based on TCM |
| van Steenbergen et al., 2022 [27] (Netherlands, RCT) | Adults >18 scheduled for elective/urgent isolated CABG | Int: 67.9; Ctrl: 69.6 | Int: 136; Ctrl: 135 | Discharge; 1,2,3,6w | eHealth, videos, 2 video consultations |
| İlgin et al., 2024 [30] (Turkey, RCT) | Adults ≥18 after CABG discharge | Int: 58.60 (8.75); Ctrl: 58.66 (10.41) | Int: 30; Ctrl: 30 | 4 weeks post-discharge | Weekly telephone/video calls & counseling |
| Yadav et al., 2021 [17] (India, RCT) | Patients with ACS after successful PCI | Int: 54.3 (11.3); Ctrl: 54.2 (10.2) | Int: 109; Ctrl: 119 | 30 days | Health RADAR app |
| Nilsson et al., 2021 [25] (Sweden, RCT) | Patients ≥50 undergoing elective AAA repair (EVAR/open) | Int: 72.6 (7.2); Ctrl: 73.3 (5.8) | Int: 60; Ctrl: 60 | 4–6 weeks | 6-week early-recovery telehealth |
| Bikmoradi et al., 2023 [23] (Iran, RCT) | Patients 40–60 discharged after CABG | Int: 52.78 (6.20); Ctrl: 55.75 (8.34) | Int: 45; Ctrl: 43 | 3 times/week for 6 weeks | SMS-based follow-up |
| Barnason et al., 2009 [29] (USA, RCT) | Adults 65–85 with high preoperative burden after CABG | 71.6 (5.1) | Int: 23; Ctrl: 31 | 3 and 6 weeks; 3 and 6 months | 6-week early recovery telehealth (symptom management) |
| Study | Measurement instruments | Intervention group (Before → After) | Control group (Before → After) |
| Martorella et al., 2012 [26] | BPI; HADS; BQ-II; PCS | BPI (breathing/coughing): 4.7 (2.5) → 3.4 (2.6); HADS-A: 6.77 (4.44) → 5.37 (4.15); HADS-D: 3.67 (3.40) → 4.30 | BPI (breathing/coughing): 6.2 (2.8) → 5.0 (3.8); HADS-A: 8.32 (5.17) → 5.84 (3.25); HADS-D: 2.86 (2.29) → 4.21 (4.01) |
| Ding et al., 2024 [28] | SF-36; Self-Care Competency Scale; Morisky; PF | PF: 45.98 (0.42) → 50.12 (0.32) / 52.85 (0.52) / 57.07 (0.41) at 1/3/6m; Morisky: 5.12 (0.23) → 5.69 (0.19) / 6.43 (0.18) / 9.29 (0.23) | PF: 44.51 (0.82) → 48.19 (0.50) / 46.67 (0.89) / 45.88 (0.76); Morisky: 5.13 (0.22) → 4.89 (0.19) / 4.49 (0.17) / 4.14 (0.23) |
| Jin et al., 2020 [22] | HAMA; HAMD; PSQI; CAT; lung function | NR (baseline) → Respiratory infection: 2 (4.0%); Pulmonary infection: 2 (4.0%); Airway obstruction: 1 (2.0%) | NR (baseline) → Respiratory infection: 6 (13.0%); Pulmonary infection: 4 (8.7%); Airway obstruction: 5 (10.9%) |
| Yu et al., 2025 [31] | Office BP | SBP: 129.90 (19.59) → 117.74 (13.80); DBP: 79.88 (12.31) → 73.60 (10.18) | SBP: 129.11 (20.85) → 121.46 (16.85); DBP: 79.79 (12.89) → 75.72 (10.45) |
| Mala et al., 2026 [24] | Thai-ESDS; HADS-A; HADS-D; Rehospitalization | Thai-ESDS: 23.02 (4.19) → 17.82 (3.82) / 13.78 (3.12) at 30/90d; HADS-A: 7.94 (2.10) → 3.58 (1.64) / 1.48 (0.86); HADS-D: 4.28 (1.79) → 2.78 (1.46) / 0.85 (0.94); Rehospitalization: → 5 (11.9%) | Thai-ESDS: 21.17 (5.05) → 24.11 (6.58) / 20.46 (7.84); HADS-A: 7.97 (2.35) → 6.65 (2.87) / 5.74 (3.33); HADS-D: 4.17 (1.77) → 4.38 (2.70) / 3.63 (2.62); Rehospitalization: → 16 (38.1%) |
| van Steenbergen et al., 2022 [27] | SF-36; iMCQ; HADS-A | HADS-A: baseline p = .29 → Healthcare utilization: 31.6%; Costs: 183 (515); HADS-A at 6w: p = .69 | NR → Healthcare utilization: 45.2%; Costs: 285 (777); HADS-A: NR |
| İlgin et al., 2024 [30] | Self-Care Strength Scale | 91.60 (20.13) → 105.83 (9.99) | 88.47 (24.08) → 85.77 (27.62) |
| Yadav et al., 2021 [17] | Patient Satisfaction; Composite outcome; Controlled BP | NR → Satisfaction: 20.7 (1.29); Composite outcome: 18 (15.0%); Controlled BP: 32/42 (76.2%) | NR → Satisfaction: 16.5 (2.68); Composite outcome: 14 (12.8%); Controlled BP: 18/40 (45.0%) |
| Nilsson et al., 2021 [25] | HADS-A; HADS-D; SF-12 (PCS/MCS) | HADS-A: 4.68 (3.80) → mean change −2.00 (app users); HADS-D: NR; SF-12: NR | HADS-A: 3.83 (3.87) → mean change −0.54; HADS-D: NR; SF-12: NR |
| Bikmoradi et al., 2023 [23] | DASS-21 | Depression: 11.95 (4.08) → 7.85 (2.33); Anxiety: 18.17 (3.87) → 10.45 (3.46); Stress: 18.75 (4.80) → 10.50 (2.10) | Depression: 11.55 (2.54) → 10.56 (2.58); Anxiety: 17.40 (2.03) → 16.50 (3.64); Stress: 18.37 (2.62) → 17.90 (2.77) |
| Barnason et al., 2009 [29] | RT3 accelerometer; Activity Diary; MOS SF-36; RISKO | RT3: NR → Energy expenditure: 27.9 kcal/kg/day | RT3: NR → Energy expenditure: 26.6 kcal/kg/day |
| Study | D1: Randomization process | D2: Deviations from intended interventions | D3: Missing outcome data | D4: Measurement of the outcome | D5: Selection of the reported result | Overall risk of bias |
| Martorella et al., 2012 | Low | Some concerns | Some concerns | High | Some concerns | High risk |
| Ding et al., 2024 | Low | Some concerns | Low | Low | Some concerns | Some concerns |
| Jin et al., 2020 | Low | Some concerns | Some concerns | Low | Some concerns | Some concerns |
| Yu et al., 2025 | Low | Low | Low | Low | Some concerns | Some concerns |
| Mala et al., 2026 | Low | Low | Low | Some concerns | Low | Some concerns |
| van Steenbergen et al., 2022 | Some concerns | Low | Low | Some concerns | Low | Some concerns |
| İlgin et al., 2024 | Some concerns | Some concerns | Low | Some concerns | Some concerns | Some concerns |
| Yadav et al., 2021 | Low | Some concerns | Low | Some concerns | Some concerns | Some concerns |
| Nilsson et al., 2021 | Low | Some concerns | Some concerns | Low | Some concerns | Some concerns |
| Bikmoradi et al., 2023 | Some concerns | Some concerns | Some concerns | High | Some concerns | High risk |
| Barnason et al., 2009 | Some concerns | Some concerns | Some concerns | Some concerns | Some concerns | Some concerns |
| Outcome Domain | Number of Studies (n) | Studies Reporting Beneficial Effect | Studies Reporting No Significant Effect | Studies Reporting Mixed/Inconclusive | Consistency of Evidence* |
| Anxiety/Depression/Stress | 6 | 4 | 2 | 0 | Moderate |
| Sleep Quality | 2 | 2 | 0 | 0 | Low |
| Quality of Life | 4 | 2 | 1 | 1 | Low-Moderate |
| Pain | 1 | 0 | 1 | 0 | Insufficient |
| Self-Care/Adherence | 3 | 3 | 0 | 0 | Moderate |
| Functional Status | 3 | 3 | 0 | 0 | Low-Moderate |
| Healthcare Utilization/Readmission | 2 | 2 | 0 | 0 | Low |
| Clinical Outcomes (BP, complications) | 3 | 2 | 1 | 0 | Low |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |